Europe — EMA
Zaltrap (Aflibercept)
Zaltrap (Aflibercept) is a prescription medication used for cancer treatment. It belongs to the class of VEGF inhibitors, targeting blood vessel growth in tumor
Request sourcing
What is Aflibercept?
Zaltrap (Aflibercept) is a prescription medication used for cancer treatment. It belongs to the class of VEGF inhibitors, targeting blood vessel growth in tumors. This overview covers its uses, effects, and safety notes for general awareness.
What is Aflibercept used for?
Zaltrap (Aflibercept) is primarily used to treat metastatic colorectal cancer in combination with other chemotherapy drugs. It works by blocking vascular endothelial growth factor (VEGF), which helps slow tumor growth by reducing blood supply to cancerous tissues. Patients and caregivers often ask, 'what is Zaltrap used for' to understand its role in cancer therapy.
What are the side effects of Aflibercept?
Zaltrap may help slow the progression of certain cancers by interfering with tumor blood supply. Common effects include fatigue, diarrhea, and mouth sores, which vary by individual. These effects are not guaranteed and may differ based on treatment duration and patient health.
What precautions apply to Aflibercept?
Zaltrap should only be handled and administered by healthcare professionals due to its intravenous use. Patients with bleeding disorders or recent surgeries may need special monitoring. Always inform your doctor about current medications and health conditions before starting treatment.
What does Aflibercept interact with?
Zaltrap may interact with other drugs that affect blood clotting or blood pressure. Combining it with certain chemotherapy agents could increase side effects. Alcohol and herbal supplements should be discussed with a healthcare provider to avoid potential interactions.
